SOX30 and prostate cancer: Moreover, it was discovered that a lower SOX30 expression in Prostate Cancer (PC) cells compared to normal tissue cells is caused by the inhibiting effect of miR-653-5p’s interaction with the SOX30 transcript, which results in the downregulation of Wnt/β-catenin signaling.